ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 197 filers reported holding ARIAD PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.15 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,222,000 | +39.4% | 178,632 | +53.4% | 0.00% | 0.0% |
| Q3 2016 | $1,594,000 | +99.2% | 116,427 | +7.6% | 0.00% | – |
| Q2 2016 | $800,000 | +9.4% | 108,222 | -5.4% | 0.00% | – |
| Q1 2016 | $731,000 | +26.3% | 114,370 | +23.4% | 0.00% | – |
| Q4 2015 | $579,000 | +31.9% | 92,682 | +23.2% | 0.00% | – |
| Q3 2015 | $439,000 | -78.6% | 75,229 | -69.6% | 0.00% | -100.0% |
| Q2 2015 | $2,047,000 | -54.8% | 247,556 | -55.0% | 0.00% | 0.0% |
| Q1 2015 | $4,530,000 | +137.2% | 549,640 | +91.0% | 0.00% | 0.0% |
| Q4 2014 | $1,910,000 | +45.8% | 287,752 | +14.2% | 0.00% | 0.0% |
| Q3 2014 | $1,310,000 | +101.8% | 251,951 | +147.4% | 0.00% | – |
| Q2 2014 | $649,000 | -8.2% | 101,837 | +16.1% | 0.00% | – |
| Q1 2014 | $707,000 | +77.6% | 87,693 | +50.4% | 0.00% | – |
| Q4 2013 | $398,000 | -95.5% | 58,313 | -87.8% | 0.00% | -100.0% |
| Q3 2013 | $8,797,000 | +0.1% | 478,106 | -4.9% | 0.00% | -20.0% |
| Q2 2013 | $8,791,000 | – | 502,737 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $175,916,000 | 40.51% |
| Consonance Capital Management LP | 8,695,742 | $119,045,000 | 11.46% |
| Tamarack Advisers, LP | 3,700,000 | $49,358,000 | 7.76% |
| Opaleye Management Inc. | 1,045,000 | $14,306,000 | 7.49% |
| Granite Point Capital Management, L.P. | 457,415 | $6,262,000 | 2.44% |
| Redmile Group, LLC | 2,138,471 | $29,276,000 | 2.33% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 206,010 | $2,820,000 | 2.17% |
| Palo Alto Investors LP | 2,587,617 | $35,424,000 | 2.06% |
| PRICE MICHAEL F | 940,000 | $12,869,000 | 1.71% |
| HighVista Strategies LLC | 638,086 | $8,735,000 | 1.62% |